Hereditary motor and sensory neuropathies or Charcot-Marie-Tooth diseases: An update

Journal of the Neurological Sciences

Volumn 347, Issue 1-2, 2014, Pages 14-22

  Tazir, Meriem ^a,b   Hamadouche, Tarik ^b,c   Nouioua, Sonia ^a,b   Mathis, Stephane ^d   Vallat, Jean Michel ^e  

^a CHU Mustapha   (Algeria)

^b Benyoucef Benkhedda   (Algeria)

^c UNIVERSITY OF BOUMERDES   (Algeria)

^d UNIVERSITÉ DE POITIERS   (France)

^e LIMOGES UNIVERSITY HOSPITAL   (France)

Author keywords

AR CMT1; AR CMT2; Charcot Marie Tooth disease (CMT); HMSN; NGS; PXT3003 trial

Indexed keywords

BACLOFEN; GAP JUNCTION PROTEIN; GAP JUNCTION PROTEIN BETA 1; MITOFUSIN 2; MYELIN PROTEIN; MYELIN PROTEIN ZERO; NALTREXONE; PERIPHERAL MYELIN PROTEIN 22; PXT 3003; SORBITOL; UNCLASSIFIED DRUG; GDAP PROTEIN; NERVE PROTEIN;

AUTOSOMAL DOMINANT INHERITANCE; DISEASE CLASSIFICATION; FOUNDER EFFECT; GENE FREQUENCY; GENE MUTATION; GENETIC HETEROGENEITY; GENETIC SCREENING; HEREDITARY MOTOR SENSORY NEUROPATHY; HUMAN; MOLECULAR DIAGNOSIS; NEXT GENERATION SEQUENCING; PERIPHERAL NERVE INJURY; PHENOTYPE; RECESSIVE GENE; REVIEW; CLASSIFICATION; DEMYELINATING DISEASE; FEMALE; GENETICS; MALE; METABOLISM; PATHOLOGY; PERIPHERAL NERVE;

CHARCOT-MARIE-TOOTH DISEASE; DEMYELINATING DISEASES; FEMALE; GENETIC TESTING; HEREDITARY SENSORY AND MOTOR NEUROPATHY; HUMANS; MALE; NERVE TISSUE PROTEINS; PERIPHERAL NERVES;

EID: 84920026337     PISSN: 0022510X     EISSN: 18785883     Source Type: Journal    
DOI: 10.1016/j.jns.2014.10.013     Document Type: Review

References (55)

1. P.J. Dyck, and E.H. Lambert Lower motor and primary sensory neuron diseases with peroneal muscular atrophy. Neurologic, genetic, and electrophysiological findings in hereditary polyneuropathies Arch Neurol 18 1968 603 608
2. P.K. Thomas, and D.B. Calne Motor nerve conduction velocity in peroneal muscular atrophy: evidence for genetic heterogeneity J Neurol Neurosurg Psychiatry 37 1974 68 75
3. A.E. Harding, and P.K. Thomas The clinical features of hereditary motor and sensory neuropathy types I and II Brain 103 1980 259 280
4. A.E. Harding, and P.K. Thomas Autosomal recessive forms of hereditary motor and sensory neuropathy J Neurol Neurosurg Psychiatry 43 1980 669 678
5. J. Bergoffen, S.S. Scherer, S. Wang, M.O. Scott, L.J. Bone, and D.L. Paul Connexin mutations in X-linked Charcot-Marie-Tooth disease Science 262 1993 2039 2042
6. N. Birouk, E. LeGuern, T. Maisonobe, H. Rouger, R. Gouider, and S. Tardieu X-linked Charcot-Marie-Tooth disease with connexin 32 mutations: clinical and electrophysiologic study Neurology 50 1998 1074 1082
7. C.E. Siskind, and M.E. Shy Genetics of neuropathies Semin Neurol 31 2011 494 505
8. O. Dubourg, H. Azzedine, C. Verny, G. Durosier, N. Birouk, and R. Gouider Autosomal-recessive forms of demyelinating Charcot-Marie-Tooth disease Neuromolecular Med 8 2006 75 86
9. J.R. Lupski, R.M. de Oca-Luna, S. Slaugenhaupt, L. Pentao, V. Guzzetta, and B.J. Trask DNA duplication associated with Charcot-Marie-Tooth disease type 1A Cell 66 1991 219 232
10. P. Raeymaekers, V. Timmerman, E. Nelis, P. De Jonghe, J.E. Hoogendijk, and F. Baas Duplication in chromosome 17p11.2 in Charcot-Marie-Tooth neuropathy type 1a (CMT 1a) Neuromuscul Disord 1 1991 93 97
11. S.M. Murphy, D.N. Herrmann, M.P. McDermott, S.S. Scherer, M.E. Shy, and M.M. Reilly Reliability of the CMT neuropathy score (second version) in Charcot-Marie-Tooth disease J Peripher Nerv Syst 16 2011 191 198
12. J.M. Vallat, D. Grid, C. Magdelaine, F. Sturtz, N. Levy, and M. Tazir Autosomal recessive forms of Charcot-Marie-Tooth disease Bull Acad Natl Med 189 2005 55 68
13. S.W. Yum, J. Zhang, K. Mo, J. Li, and S.S. Scherer A novel recessive Nefl mutation causes a severe, early-onset axonal neuropathy Ann Neurol 66 2009 759 770
14. J.M. Vallat, S. Mathis, and B. Funalot The various Charcot-Marie-Tooth diseases Curr Opin Neurol 26 2013 473 480
15. A.S. Saporta, S.L. Sottile, L.J. Miller, S.M. Feely, C.E. Siskind, and M.E. Shy Charcot-Marie-Tooth disease subtypes and genetic testing strategies Ann Neurol 69 2011 22 33
16. S.M. Murphy, M. Laura, K. Fawcett, A. Pandraud, Y.T. Liu, and G.L. Davidson Charcot-Marie-Tooth disease: frequency of genetic subtypes and guidelines for genetic testing J Neurol Neurosurg Psychiatry 83 2012 706 710
17. B. Gess, A. Schirmacher, M. Boentert, and P. Young Charcot-Marie-Tooth disease: frequency of genetic subtypes in a German neuromuscular center population Neuromuscul Disord 23 2013 647 651
18. R. El-Abassi, J.D. England, and G.T. Carter Charcot-Marie-Tooth disease: an overview of genotypes, phenotypes, and clinical management strategies PMR 6 2014 342 355
19. P.J. Dyck Neuronal atrophy and degeneration predominantly affecting peripheral sensory and autonomic neurons P.J. Dyck, P.K. Thomas, J.W. Griffin, P.A. Low, J.F. Poduslo, Peripheral neuropathy 1993 W.B Saunders Philadelphia 1065 1093
20. A. Rotthier, J. Baets, E. De Vriendt, A. Jacobs, M. Auer-Grumbach, and N. Lévy Genes for hereditary sensory and autonomic neuropathies: a genotype-phenotype correlation Brain 132 2009 2699 2711
21. G. Davidson, S. Murphy, J. Polke, M. Laura, M. Salih, and F. Muntoni Frequency of mutations in the genes associated with hereditary sensory and autonomic neuropathy in a UK cohort J Neurol 8 2012 1673 1685
22. M. Auer-Grumbach, M. Weger, R. Fink-Puches, L. Papic, E. Fröhlich, and P. Auer-Grumbach Fibulin-5 mutations link inherited neuropathies; age-related macular degeneration and hyperelastic skin Brain 134 2011 1839 1852
23. S.M. Feely, M. Laura, C.E. Siskind, S. Sottile, M. Davis, and V.S. Gibbons MFN2 mutations cause severe phenotypes in most patients with CMT2A Neurology 76 2011 1690 1696
24. K.W. Chung, S.B. Kim, K.D. Park, K.G. Choi, J.H. Lee, and H.W. Eun Early onset severe and late-onset mild Charcot-Marie-Tooth disease with mitofusin 2 (MFN2) mutations Brain 129 2006 2103 2118
25. J. Calvo, B. Funalot, R.A. Ouvrier, L. Lazaro, A. Toutain, and P. De Mas Genotype-phenotype correlations in Charcot-Marie-Tooth disease type 2 caused by mitofusin 2 mutations Arch Neurol 66 2009 1511 1516
26. J.M. Polke, M. Laura, D. Pareyson, F. Taroni, M. Milani, and G. Bergamin Recessive axonal Charcot-Marie-Tooth disease due to compound heterozygous mitofusin 2 mutations Neurology 77 2011 168 173
27. P. Solla, A. Vannelli, A. Bolino, G. Marrosu, S. Coviello, and M.R. Murru Heat shock protein 27 R127W mutation: evidence of a continuum between axonal Charcot-Marie-Tooth and distal hereditary motor neuropathy J Neurol Neurosurg Psychiatry 81 2010 958 962
28. C.F. Boerkoel, H. Takashima, C.A. Garcia, R.K. Olney, J. Johnson, and K. Berry Charcot-Marie-Tooth disease and related neuropathies: mutation distribution and genotype-phenotype correlation Ann Neurol 51 2002 190 201
29. N. Hattori, M. Yamamoto, T. Yoshihara, H. Koike, M. Nakagawa, and H. Yoshikawa Demyelinating and axonal features of Charcot-Marie-Tooth disease with mutations of myelin-related proteins (PMP22, MPZ and Cx32): a clinicopathological study of 205 Japanese patients Brain 126 2003 134 151
30. C. Rinaldi, C. Grunseich, I.F. Sevrioukova, A. Schindler, I. Horkayne-Szakaly, and C. Lamperti Cowchock syndrome is associated with a mutation in apoptosis-inducing factor Am J Hum Genet 91 2012 1095 1102
31. J. Park, Y.S. Hyun, Y.J. Kim, S.H. Nam, S.H. Kim, and Y.B. Hong Exome sequencing reveals a novel PRPS1 mutation in a family with CMTX5 without optic atrophy J Clin Neurol 9 2013 283 288
32. G. Nicholson, and S. Myers Intermediate forms of Charcot-Marie-Tooth neuropathy: a review Neuromolecular Med 8 2006 123 130
33. O. Boyer, F. Nevo, E. Plaisier, B. Funalot, O. Gribouval, and G. Benoit INF2 mutations in Charcot-Marie-Tooth disease with glomerulopathy N Engl J Med 365 2011 2377 2388
34. I. Mademan, T. Deconinck, A. Dinopoulos, T. Voit, U. Schara, and K. Devriendt De novo INF2 mutations expand the genetic spectrum of hereditary neuropathy with glomerulopathy Neurology 81 2013 1953 1958
35. S. Mathis, B. Funalot, O. Boyer, C. Lacroix, P. Marcorelles, and L. Magy Neuropathologic characterization of INF2-related Charcot-Marie-Tooth disease: Evidence for a Schwann cell actinopathy J Neuropathol Exp Neurol 73 2014 223 233
36. D. Kabzinska, A. Niemann, H. Drac, N. Huber, A. Potulska-Chromik, and I. Hausmanowa-Petrusewicz A new missense GDAP1 mutation disturbing targeting to the mitochondrial membrane causes a severe form of AR-CMT2C disease Neurogenetics 12 2011 145 153
37. H.M. McLaughlin, R. Sakaguchi, C. Liu, T. Igarashi, D. Pehlivan, and K. Chu Compound heterozygosity for loss-of-function lysyl-tRNA synthetase mutations in a patient with peripheral neuropathy Am J Hum Genet 87 2010 560 566
38. H. Azzedine, P. Zavadakova, V. Planté-Bordeneuve, M. Vaz Pato, N. Pinto, and L. Bartesaghi PLEKHG5 deficiency leads to an intermediate form of autosomal recessive Charcot-Marie-Tooth disease Hum Mol Genet 22 2013 4224 4232
39. M. Tazir, M. Bellatache, S. Nouioua, and J.M. Vallat Autosomal recessive Charcot-Marie-Tooth disease: from genes to phenotypes J Peripher Nerv Syst 18 2013 113 129
40. R. Claramunt, L. Pedrola, T. Sevilla, A. Lopez de Munain, J. Berciano, and A. Cuesta Genetics of Charcot-Marie-Tooth disease type 4A: mutations, inheritance, phenotypic variability, and founder effect J Med Genet 42 2005 358 365
41. I. Gosselin, I. Thiffault, M. Tétreault, V. Chau, M.J. Dicaire, and L. Loisel Founder SH3TC2 mutations are responsible for a CMT4C French-Canadians cluster Neuromuscul Disord 18 2008 483 492
42. L. Kalaydjieva, D. Gresham, R. Gooding, L. Heather, F. Baas, and R. de Jonge N-myc downstream-regulated gene 1 is mutated in hereditary motor and sensory neuropathy-Lom Am J Hum Genet 67 2000 47 58
43. T. Hamadouche, Y. Poitelon, E. Genin, M. Chaouch, M. Tazir, and N. Kassouri Founder effect and estimation of the age of the c.892C > T (p.Arg298Cys) mutation in LMNA associated to Charcot-Marie-Tooth subtype CMT2B1 in families from North Western Africa Ann Hum Genet 72 2008 590 597
44. J.M. Vallat, R.A. Ouvrier, J.D. Pollard, C. Magdelaine, D. Zhu, and G.A. Nicholson Histopathological findings in hereditary motor and sensory neuropathy of axonal type with onset in early childhood associated with mitofusin 2 mutations J Neuropathol Exp Neurol 67 2008 1097 1102
45. A. Leal, B. Morera, G. Del Valle, D. Heuss, C. Kayser, and M. Berghoff A second locus for an axonal form of autosomal recessive Charcot-Marie-Tooth disease maps to chromosome 19q13.3 Am J Hum Genet 68 2001 269 274
46. B.O. Choi, S.K. Koo, M.H. Park, H. Rhee, S.J. Yang, and K.G. Choi Exome sequencing is an efficient tool for genetic screening of Charcot-Marie-Tooth disease Hum Mutat 33 2012 1610 1615
47. J.R. Lupski, C. Gonzaga-Jauregui, Y. Yang, M.N. Bainbridge, S. Jhangiani, and C.J. Buhay Exome sequencing resolves apparent incidental findings and reveals further complexity of SH3TC2 variant alleles causing Charcot-Marie-Tooth neuropathy Genome Med 5 2013 57
48. A.M. Rossor, J.M. Polke, H. Houlden, and M.M. Reilly Clinical implications of genetic advances in Charcot-Marie-Tooth disease Nat Rev Neurol 9 2013 562 571
49. G. Landoure, J.M. Sullivan, J.O. Johnson, C.H. Munns, Y. Shi, and O. Diallo Exome sequencing identifies a novel TRPV4 mutation in a CMT2C family Neurology 79 2012 192 194
50. P. Young, P. De Jonghe, F. Stogbauer, and T. Butterfass-Bahloul Treatment for Charcot-Marie-Tooth disease Cochrane Database Syst Rev 1 2008 CD006052
51. E. Passage, J.C. Norreel, P. Noack-Fraissignes, V. Sanguedolce, J. Pizant, and X. Thirion Ascorbic acid treatment corrects the phenotype of a mouse model of Charcot-Marie-Tooth disease Nat Med 10 2004 396 401
52. D. Pareyson, M.M. Reilly, A. Schenone, G.M. Fabrizi, T. Cavallaro, and L. Santoro Randomised double-blind controlled trial of ascorbic acid in Charcot-Marie-Tooth type 1A (CMT-TRIAAL/CMT-TRAUK) Lancet Neurol 10 2011 320 328
53. R.A. Lewis, M.P. McDermott, D.N. Herrmann, A. Hoke, L.L. Clawson, and C. Siskind High-dosage ascorbic acid treatment in Charcot-Marie-Tooth disease type 1A: results of a randomized, double-masked, controlled trial JAMA Neurol 24 2013 1 7
54. E.E. Schadt, S.H. Friend, and D.A. Shaywitz A network view of disease and compound screening Nat Rev Drug Discov 8 2009 286 295
55. S. Attarian, O. Dubourg, B. Funalot, P.M. Gonnaud, A. Lacour, and L. Magy A phase II randomized, placebo-controlled multicenter clinical trial of three doses of PXT3003 in 80 adult patients with CMT1A treated for 1 year J Peripher Nerv Syst 18 2013 S7 S8 [Suppl.]